お見積

サンプルお申込み

お問い合わせ

今すぐ購入

※ご注文方法：お問い合わせフォームまたはメールにてご連絡ください。
支払方法：「銀行振込」の場合， 注文の確認後、ご指定のメールアドレスに電子版の請求書をお送りいたしますので、電子版の請求書の記載事項に従って送金操作を行ってください。
※納期：原則として、受注後2～4営業日以内に発送いたします。 但し、日本語版が必要な場合は、受注後8～10営業日となります。 お客様のニーズに合わせて、事前にご注文のスケジュールをお立てください。

本報告書はワクチンと予防接種市場規模の世界市場の概要を紹介します。2019~2023年の歴史的な市場収益データ、2024年の予想、および2030年までのCAGRの予測を含む世界市場動向の分析。レポートはワクチンと予防接種の主要メーカーを詳細に分析し、地域別・国別の収益プロフィールを明らかにしています。 本レポートでは特に、主要地域/国別のセグメントとサブセグメントについて、将来の市場ポテンシャルの探索と予測に焦点を当てています。 複数の地域にわたる包括的なデータと市場価値分析により、読者は包括的かつ詳細な市場洞察を得ることができます。

世界のワクチンと予防接種市場の主な参加者である企業概要、収益、粗利益率、ポートフォリオ、地理的位置、重要な発展について、次のパラメータに基づいて説明します。レポートはワクチンと予防接種のメーカー、地域、種類と端末業界の角度から世界と主要地域の市場現状と将来性を研究した、このレポートでは、世界と主要地域のトップメーカーを分析し、タイプとアプリケーション/端末業界別にワクチンと予防接種市場を分類しています。本研究に含まれる主な企業は：Abbott、AstraZeneca、Bavarian Nordic、Novartis、Bharat Biotech、Bio-Med、CSL、Emergent BioSolutions、GSK、Johnson & Johnson、Pfizer、Merck、Sanofi

地域別市場区分、地域別分析は以下の通り：
    アメリカとカナダ
    中国
    アジア
    ヨーロッパ
    中東、アフリカ、ラテンアメリカ

タイプ別市場セグメント：
    Subunit vaccines
    Live attenuated vaccines
    Conjugate vaccines
    Inactivated vaccines
    Recombinant vector vaccines
    Toxoid vaccines
    Synthetic vaccines
    Dendritic cell vaccines

用途別の市場セグメント：
    Baby Vaccine
    Adult Special Vaccine
    Other

本レポートの詳細内容
世界のワクチンと予防接種市場の現状と将来について、グローバルの主要地域を中心に包括的に分析しています。 当レポートでは、多角的な分析を通じて、市場プレイヤー、地域分布、ワクチンと予防接種タイプ、最終用途アプリケーションなどの主要分野を掘り下げ、読者に包括的な市場洞察を提供しています。 レポートは主要企業のワクチンと予防接種収益、市場シェア、業界ランキング、2019年から2024年までのデータに焦点を当てています。世界のワクチンと予防接種市場における主要なステークホルダーの特定、最近の動向とセグメント収益に基づいて競争状況と市場ポジショニングの分析。また、当レポートでは、世界市場の主要プレイヤーを特定し、プロファイルを作成するとともに、ワクチンと予防接種市場を綿密に分類・応用することで、読者が市場構造とダイナミクスをより正確に把握できるようにし、十分な情報に基づいた意思決定と戦略立案に強力なサポートを提供しています。

ワクチンと予防接種のレポートは2019年から2030年までのタイプ別およびアプリケーション別、収益、成長率別のセグメントデータを分析します。収益、予測成長傾向、アプリケーション、およびエンドユーザー業界の市場規模を評価および予測します。

章の概要
第1章：ワクチンと予防接種のレポートの報告範囲、各セグメントの市場規模、将来の開発可能性などを含む、さまざまな市場セグメント（製品タイプ、用途など）のエグゼクティブサマリーを紹介します。市場の現状と、短期から中期、および長期的な進化の可能性をハイレベルに見ることができます。（2019～2030）
第2章：ワクチンと予防接種の世界及び地域レベルでの売上高。各地域とその主要国の市場規模と発展の可能性を定量的に分析し、世界各国の市場発展、今後の発展展望、市場空間、生産能力などを紹介する。また、市場ダイナミクス、市場の最新動向、市場の推進要因と制限要因、業界企業が直面する課題とリスク、業界の関連政策の分析などを紹介しています。（2019～2030）
第3章ワクチンと予防接種企業の競争状況、収益、市場シェアと業界ランキング、最新の開発計画、合併・買収情報などの詳細分析。（2019～2030）
第4章：各市場セグメントの収益と開発の可能性をカバーし、種類別のさまざまな市場セグメントの分析を提供し、読者がさまざまな市場セグメントでブルーオーシャン市場を見つけるのに役立ちます。（2019～2024）
第5章：ワクチンと予防接種の各市場セグメントの収益と開発の可能性をカバーするアプリケーション別のさまざまな市場セグメントの分析を提供し、読者がさまざまな下流市場でブルーオーシャン市場を見つけるのに役立ちます。（2019～2030）
第6章：北米（米国、カナダ）のタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第7章：ヨーロッパのタイプ別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第8章：中国の種類別、および用途別、各セグメントの収益。（2019～2030）
第9章アジア（中国を除く）の種類別、用途別、地域別、セグメントごとの収益。（2019～2030）
第10章：中東、アフリカ、ラテンアメリカの種類別、アプリケーション別、国別、各セグメントの収益。（2019～2030）
第11章：ワクチンと予防接種の主要企業の概要を提供し、製品の説明と仕様、ワクチンと予防接種の収益、粗利益率、最近の展開など、市場の主要企業の基本状況を詳細に紹介します。（2019～2024）
第12章：アナリストの見解/結論

Market Analysis and Insights: Global Vaccines & Vaccination Market
The global Vaccines & Vaccination market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Vaccines & Vaccination is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Vaccines & Vaccination is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The Europe market for Vaccines & Vaccination is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The global key companies of Vaccines & Vaccination include Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc. In 2023, the global top five players had a share approximately % in terms of revenue.
Vaccines & Vaccination is widely used in various fields, such as Baby Vaccine, Adult Special Vaccine and Other,, etc. Baby Vaccine provides greatest supports to the Vaccines & Vaccination industry development. In 2023, global % revenue of Vaccines & Vaccination went into Baby Vaccine filed and the proportion will reach to % in 2030. 
Report Covers:
This report presents an overview of global market for Vaccines & Vaccination market size. Analyses of the global market trends, with historic market revenue data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030. 
This report researches the key producers of Vaccines & Vaccination, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Vaccines & Vaccination, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.
This report focuses on the Vaccines & Vaccination revenue, market share and industry ranking of main companies, data from 2019 to 2024. Identification of the major stakeholders in the global Vaccines & Vaccination market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2019 to 2030. Evaluation and forecast the market size for Vaccines & Vaccination revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Abbott, AstraZeneca, Bavarian Nordic, Novartis, Bharat Biotech, Bio-Med, CSL, Emergent BioSolutions and GSK, etc.

Market Segmentation
By Company
    Abbott
    AstraZeneca
    Bavarian Nordic
    Novartis
    Bharat Biotech
    Bio-Med
    CSL
    Emergent BioSolutions
    GSK
    Johnson & Johnson
    Pfizer
    Merck
    Sanofi

Segment by Type
    Subunit vaccines
    Live attenuated vaccines
    Conjugate vaccines
    Inactivated vaccines
    Recombinant vector vaccines
    Toxoid vaccines
    Synthetic vaccines
    Dendritic cell vaccines

Segment by Application
    Baby Vaccine
    Adult Special Vaccine
    Other

By Region
    North America
        United States
        Canada
    Europe
        Germany
        France
        UK
        Italy
        Russia
        Nordic Countries
        Rest of Europe
    China
    Asia (excluding China)
        Japan
        South Korea
        China Taiwan
       Southeast Asia
        India
    Latin America, Middle East & Africa
        Brazil
        Mexico
        Turkey
        Israel
        GCC Countries

Chapter Outline
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Vaccines & Vaccination in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Vaccines & Vaccination companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America (US & Canada) by Type, by Application and by country, revenue for each segment.
Chapter 7: Europe by Type, by Application and by country, revenue for each segment.
Chapter 8: China by Type, and by Application, revenue for each segment.
Chapter 9: Asia (excluding China) by Type, by Application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by Type, by Application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Vaccines & Vaccination revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions

List of Tables
    Table 1. Global Vaccines & Vaccination Market Size Growth Rate by Type (US$ Million), 2019 VS 2023 VS 2030
    Table 2. Key Players of Subunit vaccines
    Table 3. Key Players of Live attenuated vaccines
    Table 4. Key Players of Conjugate vaccines
    Table 5. Key Players of Inactivated vaccines
    Table 6. Key Players of Recombinant vector vaccines
    Table 7. Key Players of Toxoid vaccines
    Table 8. Key Players of Synthetic vaccines
    Table 9. Key Players of Dendritic cell vaccines
    Table 10. Global Vaccines & Vaccination Market Size Growth Rate by Application (US$ Million), 2019 VS 2023 VS 2030
    Table 11. Global Vaccines & Vaccination Market Size Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 12. Global Vaccines & Vaccination Market Size by Region (2019-2024) & (US$ Million)
    Table 13. Global Vaccines & Vaccination Market Share by Region (2019-2024)
    Table 14. Global Vaccines & Vaccination Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 15. Global Vaccines & Vaccination Market Share by Region (2025-2030)
    Table 16. Vaccines & Vaccination Market Trends
    Table 17. Vaccines & Vaccination Market Drivers
    Table 18. Vaccines & Vaccination Market Challenges
    Table 19. Vaccines & Vaccination Market Restraints
    Table 20. Global Vaccines & Vaccination Revenue by Players (2019-2024) & (US$ Million)
    Table 21. Global Vaccines & Vaccination Revenue Share by Players (2019-2024)
    Table 22. Global Top Vaccines & Vaccination by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2023)
    Table 23. Global Vaccines & Vaccination Industry Ranking 2022 VS 2023 VS 2024
    Table 24. Global 5 Largest Players Market Share by Vaccines & Vaccination Revenue (CR5 and HHI) & (2019-2024)
    Table 25. Global Key Players of Vaccines & Vaccination, Headquarters and Area Served
    Table 26. Global Key Players of Vaccines & Vaccination, Product and Application
    Table 27. Global Key Players of Vaccines & Vaccination, Product and Application
    Table 28. Mergers & Acquisitions, Expansion Plans
    Table 29. Global Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 30. Global Vaccines & Vaccination Revenue Market Share by Type (2019-2024)
    Table 31. Global Vaccines & Vaccination Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 32. Global Vaccines & Vaccination Revenue Market Share by Type (2025-2030)
    Table 33. Global Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 34. Global Vaccines & Vaccination Revenue Share by Application (2019-2024)
    Table 35. Global Vaccines & Vaccination Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 36. Global Vaccines & Vaccination Revenue Share by Application (2025-2030)
    Table 37. North America Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 38. North America Vaccines & Vaccination Market Size by Type (2025-2030) & (US$ Million)
    Table 39. North America Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 40. North America Vaccines & Vaccination Market Size by Application (2025-2030) & (US$ Million)
    Table 41. North America Vaccines & Vaccination Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 42. North America Vaccines & Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 43. North America Vaccines & Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 44. Europe Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 45. Europe Vaccines & Vaccination Market Size by Type (2025-2030) & (US$ Million)
    Table 46. Europe Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 47. Europe Vaccines & Vaccination Market Size by Application (2025-2030) & (US$ Million)
    Table 48. Europe Vaccines & Vaccination Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 49. Europe Vaccines & Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 50. Europe Vaccines & Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 51. China Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 52. China Vaccines & Vaccination Market Size by Type (2025-2030) & (US$ Million)
    Table 53. China Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 54. China Vaccines & Vaccination Market Size by Application (2025-2030) & (US$ Million)
    Table 55. Asia Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 56. Asia Vaccines & Vaccination Market Size by Type (2025-2030) & (US$ Million)
    Table 57. Asia Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 58. Asia Vaccines & Vaccination Market Size by Application (2025-2030) & (US$ Million)
    Table 59. Asia Vaccines & Vaccination Growth Rate (CAGR) by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 60. Asia Vaccines & Vaccination Market Size by Region (2019-2024) & (US$ Million)
    Table 61. Asia Vaccines & Vaccination Market Size by Region (2025-2030) & (US$ Million)
    Table 62. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Type (2019-2024) & (US$ Million)
    Table 63. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Type (2025-2030) & (US$ Million)
    Table 64. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Application (2019-2024) & (US$ Million)
    Table 65. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Application (2025-2030) & (US$ Million)
    Table 66. Middle East, Africa, and Latin America Vaccines & Vaccination Growth Rate (CAGR) by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 67. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Country (2019-2024) & (US$ Million)
    Table 68. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size by Country (2025-2030) & (US$ Million)
    Table 69. Abbott Company Details
    Table 70. Abbott Business Overview
    Table 71. Abbott Vaccines & Vaccination Product
    Table 72. Abbott Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 73. Abbott Recent Developments
    Table 74. AstraZeneca Company Details
    Table 75. AstraZeneca Business Overview
    Table 76. AstraZeneca Vaccines & Vaccination Product
    Table 77. AstraZeneca Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 78. AstraZeneca Recent Developments
    Table 79. Bavarian Nordic Company Details
    Table 80. Bavarian Nordic Business Overview
    Table 81. Bavarian Nordic Vaccines & Vaccination Product
    Table 82. Bavarian Nordic Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 83. Bavarian Nordic Recent Developments
    Table 84. Novartis Company Details
    Table 85. Novartis Business Overview
    Table 86. Novartis Vaccines & Vaccination Product
    Table 87. Novartis Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 88. Novartis Recent Developments
    Table 89. Bharat Biotech Company Details
    Table 90. Bharat Biotech Business Overview
    Table 91. Bharat Biotech Vaccines & Vaccination Product
    Table 92. Bharat Biotech Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 93. Bharat Biotech Recent Developments
    Table 94. Bio-Med Company Details
    Table 95. Bio-Med Business Overview
    Table 96. Bio-Med Vaccines & Vaccination Product
    Table 97. Bio-Med Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 98. Bio-Med Recent Developments
    Table 99. CSL Company Details
    Table 100. CSL Business Overview
    Table 101. CSL Vaccines & Vaccination Product
    Table 102. CSL Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 103. CSL Recent Developments
    Table 104. Emergent BioSolutions Company Details
    Table 105. Emergent BioSolutions Business Overview
    Table 106. Emergent BioSolutions Vaccines & Vaccination Product
    Table 107. Emergent BioSolutions Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 108. Emergent BioSolutions Recent Developments
    Table 109. GSK Company Details
    Table 110. GSK Business Overview
    Table 111. GSK Vaccines & Vaccination Product
    Table 112. GSK Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 113. GSK Recent Developments
    Table 114. Johnson & Johnson Company Details
    Table 115. Johnson & Johnson Business Overview
    Table 116. Johnson & Johnson Vaccines & Vaccination Product
    Table 117. Johnson & Johnson Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 118. Johnson & Johnson Recent Developments
    Table 119. Pfizer Company Details
    Table 120. Pfizer Business Overview
    Table 121. Pfizer Vaccines & Vaccination Product
    Table 122. Pfizer Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 123. Pfizer Recent Developments
    Table 124. Merck Company Details
    Table 125. Merck Business Overview
    Table 126. Merck Vaccines & Vaccination Product
    Table 127. Merck Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 128. Merck Recent Developments
    Table 129. Sanofi Company Details
    Table 130. Sanofi Business Overview
    Table 131. Sanofi Vaccines & Vaccination Product
    Table 132. Sanofi Revenue in Vaccines & Vaccination Business (2019-2024) & (US$ Million)
    Table 133. Sanofi Recent Developments
    Table 134. Research Programs/Design for This Report
    Table 135. Key Data Information from Secondary Sources
    Table 136. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Vaccines & Vaccination Market Size Growth Rate by Type, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 2. Global Vaccines & Vaccination Market Share by Type: 2023 VS 2030
    Figure 3. Subunit vaccines Features
    Figure 4. Live attenuated vaccines Features
    Figure 5. Conjugate vaccines Features
    Figure 6. Inactivated vaccines Features
    Figure 7. Recombinant vector vaccines Features
    Figure 8. Toxoid vaccines Features
    Figure 9. Synthetic vaccines Features
    Figure 10. Dendritic cell vaccines Features
    Figure 11. Global Vaccines & Vaccination Market Size Growth Rate by Application, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 12. Global Vaccines & Vaccination Market Share by Application: 2023 VS 2030
    Figure 13. Baby Vaccine Case Studies
    Figure 14. Adult Special Vaccine Case Studies
    Figure 15. Other Case Studies
    Figure 16. Vaccines & Vaccination Report Years Considered
    Figure 17. Global Vaccines & Vaccination Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 18. Global Vaccines & Vaccination Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 19. Global Vaccines & Vaccination Market Share by Region: 2023 VS 2030
    Figure 20. Global Vaccines & Vaccination Market Share by Players in 2023
    Figure 21. Global Top Vaccines & Vaccination Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccines & Vaccination as of 2023)
    Figure 22. The Top 10 and 5 Players Market Share by Vaccines & Vaccination Revenue in 2023
    Figure 23. North America Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 24. North America Vaccines & Vaccination Market Share by Type (2019-2030)
    Figure 25. North America Vaccines & Vaccination Market Share by Application (2019-2030)
    Figure 26. North America Vaccines & Vaccination Market Share by Country (2019-2030)
    Figure 27. United States Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Canada Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Europe Vaccines & Vaccination Market Size YoY (2019-2030) & (US$ Million)
    Figure 30. Europe Vaccines & Vaccination Market Share by Type (2019-2030)
    Figure 31. Europe Vaccines & Vaccination Market Share by Application (2019-2030)
    Figure 32. Europe Vaccines & Vaccination Market Share by Country (2019-2030)
    Figure 33. Germany Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. France Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. U.K. Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. Italy Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Russia Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Nordic Countries Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. China Vaccines & Vaccination Market Size YoY (2019-2030) & (US$ Million)
    Figure 40. China Vaccines & Vaccination Market Share by Type (2019-2030)
    Figure 41. China Vaccines & Vaccination Market Share by Application (2019-2030)
    Figure 42. Asia Vaccines & Vaccination Market Size YoY (2019-2030) & (US$ Million)
    Figure 43. Asia Vaccines & Vaccination Market Share by Type (2019-2030)
    Figure 44. Asia Vaccines & Vaccination Market Share by Application (2019-2030)
    Figure 45. Asia Vaccines & Vaccination Market Share by Region (2019-2030)
    Figure 46. Japan Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 47. South Korea Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 48. China Taiwan Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 49. Southeast Asia Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 50. India Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 51. Australia Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 52. Middle East, Africa, and Latin America Vaccines & Vaccination Market Size YoY (2019-2030) & (US$ Million)
    Figure 53. Middle East, Africa, and Latin America Vaccines & Vaccination Market Share by Type (2019-2030)
    Figure 54. Middle East, Africa, and Latin America Vaccines & Vaccination Market Share by Application (2019-2030)
    Figure 55. Middle East, Africa, and Latin America Vaccines & Vaccination Market Share by Country (2019-2030)
    Figure 56. Brazil Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 57. Mexico Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 58. Turkey Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 59. Saudi Arabia Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 60. Israel Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 61. GCC Countries Vaccines & Vaccination Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 62. Abbott Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 63. AstraZeneca Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 64. Bavarian Nordic Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 65. Novartis Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 66. Bharat Biotech Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 67. Bio-Med Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 68. CSL Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 69. Emergent BioSolutions Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 70. GSK Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 71. Johnson & Johnson Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 72. Pfizer Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 73. Merck Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 74. Sanofi Revenue Growth Rate in Vaccines & Vaccination Business (2019-2024)
    Figure 75. Bottom-up and Top-down Approaches for This Report
    Figure 76. Data Triangulation
    Figure 77. Key Executives Interviewed